https://www.taxtmi.com/article/detailed?id=15474 Indian pharmaceutical IP protection is patent centric, requiring novelty, inventive step and industrial applicability, and bars patents for mere variants lacking enhanced therapeutic efficacy to prevent evergreening. The law provides a twenty year term without routine extensions and includes compulsory licensing and opposition procedures to balance access. In the absence of standalone data exclusivity, firms rely on patents plus trade secrets and contractual measures, while trademarks, designs, copyrights and biodiversity compliance provide complementary protection. en-us Tue, 25 Nov 2025 09:38:20 +0530 Tue, 25 Nov 2025 09:38:20 +0530 TaxTMI RSS Generator https://www.taxtmi.com/article/detailed?id=15474 Indian pharmaceutical IP protection is patent centric, requiring novelty, inventive step and industrial applicability, and bars patents for mere variants lacking enhanced therapeutic efficacy to prevent evergreening. The law provides a twenty year term without routine extensions and includes compulsory licensing and opposition procedures to balance access. In the absence of standalone data exclusivity, firms rely on patents plus trade secrets and contractual measures, while trademarks, designs, copyrights and biodiversity compliance provide complementary protection. Articles Other Topics Tue, 25 Nov 2025 09:38:20 +0530 https://www.taxtmi.com/article/detailed?id=15474